Stock Events

Stock Events

GH Research

€0

0

+€0+0% Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1KA.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Compass Pathways

Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with GH Research's focus on mental health treatments.

ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health disorders, competing in the same space as GH Research.

Nuveen Municipal Income

Numinus Wellness focuses on psychedelic production and therapy, including mental health treatments, positioning it as a competitor to GH Research.

Revive Therapeutics

Revive Therapeutics explores the use of psychedelics in treatments, including mental health, which competes with GH Research's therapeutic focus.

Johnson & Johnson

Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, has developed a ketamine-based treatment for depression, competing in the mental health treatment space with GH Research.

About

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Show more...

CEO

Mr. Florian Schonharting M.Sc. (Econ)

Employees

73

Country

DE

ISIN

IE000GID8VI0

Listings

0 Comments

Share your thoughts

FAQ

What is GH Research stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange GH Research stocks are traded under the ticker 1KA.STU.

How many employees does GH Research have?▼

As of April 10, 2026, the company has 73 employees.

In which sector is GH Research located?▼

GH Research operates in the Health Care sector.

When did GH Research complete a stock split?▼

GH Research has not had any recent stock splits.

Where is GH Research headquartered?▼

GH Research is headquartered in Dublin, DE.